OrbusNeich Medical Group schedules board meeting to review interim resultsPUBT·1 day ago, 03:31 AM06929+0.27%
OrbusNeich Launches Pivotal Japan Trial for Coronary Drug-Coated BalloonTip Ranks·Jul 22 at 05:08 AM06929+0.27%
OrbusNeich targets end-2027 completion of Japan trial enrollment for proprietary drug-coated balloonPUBT·Jul 22 at 04:42 AM06929+0.27%
Pre-market trend | ORBUSNEICH (6929.HK) 5/11 Medical devices warming up, are low-level bullish signals emerging?Technical Forecast·May 11 at 08:00 PM06929+0.27%159102+0.40%
OrbusNeich Medical Group Holdings Limited (6929) Gets a Buy from CICCTip Ranks·Mar 16 at 12:25 AM06929+0.27%159883+1.38%
ORBUSNEICH's final dividend is expected to increase by 20% to 12 cents, planning to declare a regular interim dividendStheadline·Mar 13 at 02:18 AM06929+0.27%
ORBUSNEICH: Will actively consider distributing an interim dividendAASTOCKS·Mar 13 at 01:45 AM06929+0.27%
In the "Performance" report, ORBUSNEICH's annual net profit is USD 41.899 million, an increase of 5.5%, with a final dividend of HKD 0.12AASTOCKS·Mar 12 at 03:37 AM06929+0.27%516500+0.65%
09:05 ETNation's First Cardiac Arrhythmia-Focused Healthcare Network Launches with New Mexico's First ASC-Based Ablation Proceduresprnewswire·Feb 3 at 08:05 AMBBH-1.18%WCGC
ORBUSNEICH's research and production base in Hangzhou has topped outAASTOCKS·Oct 16, 2025 at 08:35 PM06929+0.27%
OrbusNeich Records Growth in 2025 Interim Results, Revenue and Net Profit Reach US$83.6 Million and US$19.8 Million RespectivelyAsian Corporate Newswire·Aug 15, 2025 at 06:38 AM06929+0.27%
ORBUSNEICH released its interim results, with a profit attributable to shareholders of USD 19.785 million, an increase of 5.08% year-on-yearZhitong·Aug 15, 2025 at 03:53 AM06929+0.27%
ORBUSNEICH will distribute a special dividend of HKD 0.15 per share on October 6thZhitong·Aug 15, 2025 at 03:45 AM06929+0.27%
